Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DaVita HealthCare Partners Inc

DVA
Current price
138.52 USD -1.48 USD (-1.06%)
Last closed 140.85 USD
ISIN US23918K1088
Sector Healthcare
Industry Medical Care Facilities
Exchange NYSE
Capitalization 10 852 857 856 USD
Yield for 12 month +4.74 %
1Y
3Y
5Y
10Y
15Y
DVA
21.11.2021 - 28.11.2021

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Address: 2000 16th Street, Denver, CO, United States, 80202

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

163.89 USD

P/E ratio

14.23

Dividend Yield

Current Year

+12 815 550 000 USD

Last Year

+12 140 147 000 USD

Current Quarter

+3 223 529 000 USD

Last Quarter

+3 294 683 000 USD

Current Year

+4 217 029 000 USD

Last Year

+3 820 430 000 USD

Current Quarter

+983 869 000 USD

Last Quarter

+1 069 312 000 USD

Key Figures DVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 2 659 367 936 USD
Operating Margin TTM 13.44 %
Price to Earnings 14.23
Return On Assets TTM 7.04 %
PEG Ratio 1.96
Return On Equity TTM 54.79 %
Wall Street Target Price 163.89 USD
Revenue TTM 12 968 523 776 USD
Book Value -3.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 5.00 %
Dividend Yield
Gross Profit TTM 4 209 318 912 USD
Earnings per share 10.09 USD
Diluted Eps TTM 10.09 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -24.50 %
Profit Margin 6.63 %

Dividend Analytics DVA

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History DVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 2:1
Payout Ratio TTM
Last Split Date 09.09.2013

Stock Valuation DVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 14.23
Forward PE 12.94
Enterprise Value Revenue 1.75
Price Sales TTM 0.84
Enterprise Value EBITDA 8.51
Price Book MRQ 21.63

Financials DVA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DVA

For 52 weeks

131.44 USD 179.60 USD
50 Day MA 145.73 USD
Shares Short Prior Month 4 426 505
200 Day MA 153.78 USD
Short Ratio 5.50
Shares Short 4 841 988
Short Percent 11.93 %